RESEARCH-USE BIOSIMILAR ANTIBODY
Rimteravimab
Antibody fragment · IgG1
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2.
TARGETSARS-CoV-2 Spike RBD
YAntibody fragment
CATALOGSC-BS-221
CATALOG NUMBERSC-BS-221
MOLECULAR WEIGHTApprox. 79.1 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2.
Rimteravimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.